.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prof. Dr. Stephan Becker

Marburg / DE

Philipps-University Marburg

Further involvements

04/03/2025
Poster
P 041
Discovery of a small molecular ligand for the Ebola virus VP30 transcription factor with antiviral activity
Antiviral therapy and resistance
04/03/2025
Poster
P 280
Immunogenicity of Two Modified Vaccinia virus Ankara (MVA)-based Candidate Vaccines encoding Lassa Virus Glycoprotein or Nucleoprotein in mice
Viral vectors and vaccines
04/03/2025
Poster
P 309
Improved Immunogenicity and Protective Capacity of Single Dose Vaccination with Stabilized Recombinant MERS-CoV Spike Antigen
Viral vectors and vaccines
04/03/2025
16:30 – 16:45 12 Min. 3 Min.
Abstract talk
O 003
Self-amplifying RNA vaccine protects mice against lethal CCHFV infection with two different virus isolates
Viral vectors and vaccines
04/03/2025
19:00 – 19:15 12 Min. 3 Min.
Abstract talk
O 022
Modified Vaccinia virus Ankara-based vaccine candidate provides cross-protection against lethal MARV challenge in a single-dose vaccination regimen
Viral vectors and vaccines
06/03/2025
Poster
P 263
Dimerization of the Ebola virus VP30 is essential for transcription and replication
Viral replication strategies
06/03/2025
09:45 – 10:00 12 Min. 3 Min.
Abstract talk
O 082
Cyclosporin A triggers a RIG-I-mediated interferon response through accumulation of mitochondrial dsRNA by impairing autophagy
Antiviral therapy and resistance
07/03/2025
12:00 – 12:15 12 Min. 3 Min.
Abstract talk
O 116
Identification and development of Sudan virus VP40 inhibitors with promising pan-filovirus activity using a crystallographic high-throughput screening
Antiviral therapy and resistance